أرسل هذا في رسالة قصيرة: Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS)

 __   _     _____    ______     _____      _____  
| || | ||  |  ___|| |      \\  |  ___||   / ___// 
| '--' ||  | ||__   |  --  //  | ||__     \___ \\ 
| .--. ||  | ||__   |  --  \\  | ||__     /    // 
|_|| |_||  |_____|| |______//  |_____||  /____//  
`-`  `-`   `-----`  `------`   `-----`  `-----`